Chemotherapy
A total of 82 (57.3%) patients completed therapy (surgery chemotherapy
and radiotherapy), while 53 (37%) did not. The event-free
survival among patients who completed treatment is 75.6%, and the
overall survival is 43.4%. See figure 1 and figure 2. Survival among
patients who completed chemotherapy, surgery, and radiotherapy is
significantly better than who did not p < .01 No
chemotherapy was given to 8(6%) patients because they were lost for
follow-up or refused treatment. One patient was given chemotherapy for
palliation.
The actuarial survival is 100 % for stage I, 73.3% for stage II
(censored), and 57 % for stage III (censored) 55% for stage IV and
16.7% for stage V.